{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:54:51Z","timestamp":1791093291772,"version":"4.1.0"},"reference-count":24,"publisher":"Japan Atherosclerosis Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT"],"published-print":{"date-parts":[[2010]]},"DOI":"10.5551\/jat.3038","type":"journal-article","created":{"date-parts":[[2011,6,16]],"date-time":"2011-06-16T13:45:38Z","timestamp":1308231938000},"page":"156-164","source":"Crossref","is-referenced-by-count":91,"title":["Safety and Exploratory Efficacy of the Novel Thrombin Receptor (PAR-1) Antagonist SCH530348 for Non-ST-Segment Elevation Acute Coronary Syndrome"],"prefix":"10.5551","volume":"17","author":[{"given":"Shinya","family":"Goto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsu","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peder","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071014"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000264509.36234.51"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.5551\/jat.12.185"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.5551\/jat.12.1"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.17.1892"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010746"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706482"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.05.012"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.07.063"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1159\/000111498"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Hirata K, Takagi H, Yamamoto M, Matsumoto T, Nishiya T, Mori K, Shimizu S, Masumoto H, Okutani Y: Ticlopi-dine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case-control study. Pharmacoge-nomics J, 2008; 8: 29-33","DOI":"10.1038\/sj.tpj.6500442"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Nakagawa Y, Nobuyoshi M, Yamaguchi T, Meguro T, Yokoi H, Kimura T, Hosoda S, Kanmatsuse K, Matsu-mori A, Sasayama S: Efficacy of abciximab for patients undergoing balloon angioplasty: data from Japanese eval-uation of c7E3 Fab for elective and primary PCI organi-zation in randomized trial (JEPPORT). Circ J, 2009; 73: 145-151","DOI":"10.1253\/circj.CJ-08-0560"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01377.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Tamura N, Kitajima I, Kawamura Y, Toda E, Eguchi Y, Ishida H, Goto S: Important regulatory role of activated platelet-derived procoagulant activity in the propagation of thrombi formed under arterial blood flow conditions. Circ J, 2009; 73: 540-548","DOI":"10.1253\/circj.CJ-08-0465"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kato Y, Kita Y, Hirasawa-Taniyama Y, Nishio M, Mihara K, Ito K, Yamanaka T, Seki J, Miyata S, Mutoh S: Inhibi-tion of arterial thrombosis by a protease-activated receptor 1 antagonist, FR171113, in the guinea pig. Eur J Phar-macol, 2003; 473: 163-169","DOI":"10.1016\/S0014-2999(03)01973-3"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1021\/jm800180e"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60230-0"},{"key":"18","unstructured":"18) Kosoglou T, Reyderman L, Kasserra C, Young S, Pei J, Maxwell SE, Schiller J, Cutler DL: Optimizing dose of the novel thrombin receptor antagonist SCH 530348 based on pharmacodynamics and pharmacokinetics in healthy subjects. Clin Pharmacol Ther, 2008; 83: S55. Abstract PII-42"},{"key":"19","unstructured":"19) Reyderman L, Kosoglou T, Kasserra C, Young S, Pei J, Schiller J, Lin H, Cutler DL: Lack of ethnic differences in the pharmacodynamics (PD) and pharmacokinetics (PK) of SCH 530348, a novel oral antiplatelet agent, in Japa-nese and Caucasian subjects. Clin Pharmacol Ther, 2009; 85: S21. Abstract PI-41"},{"key":"20","unstructured":"20) Chintala M, Vemulapalli S, Kurowski S, Sabin C, Reyn-olds D, Prevete K, Friedrichs G: SCH 530348, a novel oral antiplatelet agent, demonstrated no bleeding risk alone or in combination with aspirin and clopidogrel in cynomolgus monkeys. Arterioscl Thromb Vasc Biol, 2008; 28: e138-e139. Abstract P579"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.042663"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0610188104"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Jennings LK, Earhart A, Becker RC, Reyderman L, Veltri E, Harrington RA: Thrombin receptor antagonist (TRA; SCH530348) is a selective, potent inhibitor of PAR-1 activity with predictable pharmacokinetics. Circulation, 2007; 116: II-674. Abstract 3010","DOI":"10.1161\/circ.116.suppl_16.II_674"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1096\/fj.03-1151com"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T09:58:37Z","timestamp":1637834317000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jat\/17\/2\/17_3038\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.3038","relation":{},"ISSN":["1880-3873","1340-3478"],"issn-type":[{"value":"1880-3873","type":"electronic"},{"value":"1340-3478","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}